Cessation Therapeutics's latest lobbying report covers Q2 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs.

Cessation Therapeutics

Latest quarter: No record; Q2 2026 · 0 reports
Last 12 months: $0; Last 4 quarters
vs last quarter: No record; Q2 2026 against the quarter before
First report: Q4 2022; The first quarter a report named it

Lobbying by quarter

Cessation Therapeutics lobbying by quarter
Quarter	Amount	Reports
Q4 2022	$80K	1
Q1 2023	$80K	1
Q2 2023	$80K	1
Q3 2023	$50K	1
Q4 2023	$0	1
Q1 2024	$0	1
Q2 2024	$0	1
Q3 2024	$0	1
Q4 2024	$0	1
Q1 2025	$0	1
Q2 2025	$0	1
Q3 2025	$0	0
Q4 2025	$0	0
Q1 2026	$0	0
Q2 2026	$0	0

Policy issues the reports name

Medical research and clinical labs4 reports

A report that names several issues counts once for each.

Who was lobbied

HOUSE OF REPRESENTATIVES4 reports
SENATE4 reports

Firms it paid

Firm
Bracewell	$290K	11 quarters

Former officials lobbying for it

	Former position	Firm
ANNA KARAKITSOS	Staff Assistant, Senate Environment and Public Works Committee (2008-2009), Research Assistant/Office Manager, Senate EPW Committee (2011-2012), Professional Staff Member, Senate EPW Committee (2012-2016)	Bracewell	Q3 2023

Lobbying reports

	Filed by		Issues
25/07/21for Q2 2025	Bracewell	Under $5,000
25/04/17for Q1 2025	Bracewell	Under $5,000
25/01/21for Q4 2024	Bracewell	Under $5,000
24/10/21for Q3 2024	Bracewell	Under $5,000
24/07/22for Q2 2024	Bracewell	Under $5,000
24/04/18for Q1 2024	Bracewell	Under $5,000
24/01/22for Q4 2023	Bracewell	Under $5,000
23/10/20for Q3 2023	Bracewell	$50K	Medical research and clinical labs
23/07/20for Q2 2023	Bracewell	$80K	Medical research and clinical labs
23/04/20for Q1 2023	Bracewell	$80K	Medical research and clinical labs
23/04/20for Q4 2022	Bracewell	$80K	Medical research and clinical labs
23/01/27for Q4 2022	Bracewell	Under $5,000	Health issues